Sentien Biotechnologies
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $12M
Investors
- 6
About Sentien Biotechnologies
Sentien Biotechnologies, Inc.Founded in 2008 and headquartered in Cambridge, US, Sentien Biotechnologies, Inc. is dedicated to creating advanced therapies that leverage its unique platform. The company has undergone changes in its strategic direction over the years but remains focused on therapeutic innovations in the biotech sector. The firm was co-founded by Biju Parekkadan and Brian Miller, who has a history of involvement in the biotechnology field.Sentien Biotechnologies, Inc. specializes in innovative biotherapeutic solutions, providing advanced products designed to enhance treatment efficiency across healthcare. Their offerings cater to various medical needs, focusing on regenerative medicine.Sentien Biotechnologies, Inc. generates revenue through direct sales and strategic partnerships, primarily engaging in B2B agreements. Clients typically purchase product licenses or subscribe to services that include ongoing support and updates.Looking ahead, Sentien Biotechnologies, Inc. plans to introduce several new products aimed at enhancing patient outcomes in regenerative medicine. The company seeks to expand its market reach, specifically targeting new regions across Asia and Europe by the end of 2024.00 mn will be utilized to further develop these new therapies and support market expansion strategies, enhancing the ability to address diverse medical challenges.
Who invested in Sentien Biotechnologies
6 investors across 2 rounds
See all investors in Sentien Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sentien Biotechnologies
Who invested in Sentien Biotechnologies?
Sentien Biotechnologies has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sentien Biotechnologies raised?
Sentien Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sentien Biotechnologies last raise money?
Sentien Biotechnologies's most recent round on record is a Series A, in Apr 2017.
What does Sentien Biotechnologies do?
Sentien Biotechnologies is a biotechnology company.
Where is Sentien Biotechnologies headquartered?
Sentien Biotechnologies is headquartered in Cambridge, US.
Which VCs invest in companies like Sentien Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sentien Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sentien Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.